Heparin

"Heparin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.

Descriptor ID	D006493
MeSH Number(s)	D09.698.373.400
Concept/Terms	Heparin Heparin Unfractionated Heparin Heparin, Unfractionated Heparinic Acid Liquaemin Liquaemin Sodium Heparin Sodium Heparin Heparin, Sodium Heparin Sodium alpha-Heparin alpha-Heparin alpha Heparin

Below are MeSH descriptors whose meaning is more general than "Heparin".

Chemicals and Drugs [D]
Carbohydrates [D09]
Polysaccharides [D09.698]
Glycosaminoglycans [D09.698.373]
Heparin [D09.698.373.400]

Below are MeSH descriptors whose meaning is related to "Heparin".

Below are MeSH descriptors whose meaning is more specific than "Heparin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Heparin" by people in this website by year, and whether "Heparin" was a major or minor topic of these publications.

Bar chart showing 82 publications over 22 distinct years, with a maximum of 10 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	2	2
2002	1	2	3
2003	1	1	2
2004	2	2	4
2005	2	5	7
2006	0	2	2
2007	7	3	10
2008	5	1	6
2009	0	4	4
2010	3	1	4
2011	5	2	7
2012	2	2	4
2013	0	2	2
2014	2	2	4
2015	1	2	3
2016	3	1	4
2017	1	2	3
2018	2	0	2
2019	1	2	3
2020	0	2	2
2022	0	3	3
2023	0	1	1

Below are the most recent publications written about "Heparin" by people in Profiles.

Hernandez J, Patel H, Biddlecome P, Kildea M, Dwivedi R, Sridhara S, Silvestry S, Cavarocchi N, Francis JL, Ventura D. Evaluation of Latex Immunoturbidimetric Assay Thresholds and HIT in Cardiothoracic Surgery. Clin Appl Thromb Hemost. 2023 Jan-Dec; 29:10760296231166370.

View in: PubMed
McKenzie SE. A vision for a quicker definitive diagnosis of HIT. Blood. 2022 12 22; 140(25):2657-2658.

View in: PubMed
Parvizi J, DeMik DE, Hozack WJ, Dunbar MJ, Mont MA, Lachiewicz PF. Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It? J Arthroplasty. 2023 Jan; 38(1):1-2.

View in: PubMed
Shohat N, Ludwick L, Sutton R, Chisari E, Parvizi J. Aspirin Administered for Venous Thromboembolism Prophylaxis May Protect Against Stiffness Following Total Knee Arthroplasty. J Arthroplasty. 2022 05; 37(5):953-957.

View in: PubMed
Dove ML, Jaggi P, Kelleman M, Abuali M, Ang JY, Ballan W, Basu SK, Campbell MJ, Chikkabyrappa SM, Choueiter NF, Clouser KN, Corwin D, Edwards A, Gertz SJ, Ghassemzadeh R, Jarrah RJ, Katz SE, Knutson SM, Kuebler JD, Lighter J, Mikesell C, Mongkolrattanothai K, Morton T, Nakra NA, Olivero R, Osborne CM, Panesar LE, Parsons S, Patel RM, Schuette J, Thacker D, Tremoulet AH, Vidwan NK, Oster ME. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management. J Pediatr. 2021 02; 229:33-40.

View in: PubMed
Britt CJ, Hwang MS, Vila PM, Dang RP, Fleming SI, Patel AM, Paniello RC, Rich JT, Hanasono MM, Desai SC. Tourniquet use and factors associated with hematoma formation in free tissue transfer. Am J Otolaryngol. 2020 May - Jun; 41(3):102404.

View in: PubMed
Morita Y, Strauss E, Tanaka KA. Low ACT After High-Dose Heparin: Is Hemodilution Best Option to Pass by Syclla and Charybdis? A A Pract. 2019 12 15; 13(12):479.

View in: PubMed
Raphael J, Mazer CD, Subramani S, Schroeder A, Abdalla M, Ferreira R, Roman PE, Patel N, Welsby I, Greilich PE, Harvey R, Ranucci M, Heller LB, Boer C, Wilkey A, Hill SE, Nuttall GA, Palvadi RR, Patel PA, Wilkey B, Gaitan B, Hill SS, Kwak J, Klick J, Bollen BA, Shore-Lesserson L, Abernathy J, Schwann N, Lau WT. Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. Anesth Analg. 2019 11; 129(5):1209-1221.

View in: PubMed
Taubenberger AV, Girardo S, Tr?ber N, Fischer-Friedrich E, Kr?ter M, Wagner K, Kurth T, Richter I, Haller B, Binner M, Hahn D, Freudenberg U, Werner C, Guck J. 3D Microenvironment Stiffness Regulates Tumor Spheroid Growth and Mechanics via p21 and ROCK. Adv Biosyst. 2019 09; 3(9):e1900128.

View in: PubMed
Ezekowitz MD, Pollack CV, Halperin JL, England RD, VanPelt Nguyen S, Spahr J, Sudworth M, Cater NB, Breazna A, Oldgren J, Kirchhof P. Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial. Eur Heart J. 2018 08 21; 39(32):2959-2971.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement